Abstract
Assisted reproductive technology (ART) is increasingly influencing the fertility trends of high-income countries characterized by a pattern of delayed childbearing. However, research on the impact of ART on completed fertility is limited and the extent to which delayed births are realized later in life through ART is not well understood. This study uses data from Australian fertility clinics and national birth registries to project the contribution of ART for cohorts of women that have not yet completed their reproductive life and estimate the role played by ART in the fertility ‘recuperation’ process. Assuming that the increasing trends in ART success rates and treatment rates continue, the projection shows that the contribution of ART-conceived births to completed fertility will increase from 2.1% among women born in 1968 to 5.7% among women born in 1986. ART is projected to substantially affect the extent to which childbearing delay will be compensated at older ages, suggesting that its availability may become an important factor in helping women to achieve their reproductive plans later in life.
Similar content being viewed by others
Avoid common mistakes on your manuscript.
Introduction
In most high-income countries, childbearing has been increasingly postponed to later ages (Beaujouan, 2020; Mills et al., 2011). Delayed parenthood is associated with lower completed fertility and a higher chance of remaining permanently childless as reproductive capacity declines with age, especially among women, whose fecundity peaks in their early-20s and declines in their mid- to late-30s (Eijkemans et al., 2014). For example, Leridon’s simulation model (2004) shows that approximately 75% of women trying to conceive at age 30 will have a conception ending in a birth within one year, compared with only 66% at age 35 and 44% at age 40. With the increase in the proportion of couples experiencing age-related infertility, demand for assisted reproductive treatments has also increased.
Assisted reproductive technologies (ART), such as in vitro fertilization (IVF), where the embryo is created in the laboratory and transferred into the uterus in the hope of achieving a pregnancy, have spread rapidly, with more than 8 million ART-conceived babies being born worldwide as of 2018 (International Committee Monitoring ART and ESHRE 2018). ART has become a mainstream treatment for infertility and its contribution to total birth rates has been steadily increasing, representing the birth of up to 8% of children in some countries (Wyns et al., 2020). Yet, ART utilization rates widely vary across countries due to the existence of different regulations and health insurance schemes (Chambers et al., 2014; Präg & Mills, 2017).
Despite the continuous technological improvements, ART cannot fully compensate for the age-related decline in female reproductive performance because the effectiveness of ART also declines with age (Leridon, 2017; McCarter et al., 2021; Sartorius & Nieschlag, 2010). However, alternative treatment options such as oocyte cryopreservation (egg freezing) or the use of third-party eggs from younger donors are expanding women’s reproductive potential.
As people are having children at older ages, the contribution of ART gains relevance also for population policy. While several rationales justify the public financing of ART (Mladovsky & Sorenson, 2010), its potential positive impact on the fertility rate often assumes a central role. Assisted reproduction is now regularly included among the policy responses to low fertility rates (Gray et al., 2021; McCurry, 2020; Sobotka et al., 2019) and in some countries governments already reimburse ART with the specific aim to increase the fertility rate (Birenbaum-Carmeli, 2008; Blyth, Yee and Lee 2013; Kim, 2019). However, empirical evidence on how ART is influencing fertility trends is still limited.
Previous research in Europe and the United States has mostly focused on the impact of ART on overall fertility by adopting either a period (Habbema et al., 2009; Hoorens et al., 2007; Tierney, 2022) or cohort (Leridon, 2017; Leridon & Slama, 2008; Sobotka et al., 2008) approach, with most studies showing a rather modest contribution of 2–5%. Studies that have looked at age-specific ART fertility have found that the absolute contribution of ART to the TFR often peaks in the mid-30s, while the relative share of ART births increases with age (Burcin et al., 2020; Lazzari et al., 2021; Tierney, 2022). For example, Lazzari et al., (2021) found that increases in period fertility rates at late (40 +) reproductive ages in Australia were largely driven by the increasing use of ART.
Recent projections indicate that the future contribution of ART to Australian births will likely continue to increase because of the compositional shifts in the female population away from low and medium education towards higher levels of educational attainment, characterized by a pattern of delayed childbearing (Raymer et al., 2019). However, the contribution of ART to the completed fertility of future cohorts remains unexplored and its influence on contemporary demographic processes, such as fertility postponement and recuperation, has not yet been studied in Australia and in other developed societies.
This study has two broad aims. First, it seeks to quantify the contribution of ART to completed cohort fertility rate (CFR) in Australia. Our scenarios allow disentangling the impact of three distinct mechanisms affecting future trends in ART birth rates: women’s use of ART, ART success rates, and wider adoption of egg freezing and donor eggs among women of advanced reproductive age. Our scenarios are specified by single age and thus also account for the shifting number of women across reproductive ages, while the adoption of a cohort approach provides a better estimate of the impact of ART to fertility over time compared to period analyses. Our second aim is to investigate the role played by ART in the recovery of fertility. Looking at fertility from a life course perspective, delayed childbearing at younger ages (postponement) is followed by higher fertility at older ages (recuperation) (Frejka & Calot, 2001; Lesthaeghe, 2001). However, the realization of reproductive plans at older ages—and thus the extent of fertility recuperation—is hampered by increasing infertility (Leridon, 2004), with many couples facing involuntary childlessness. Thus, greater utilization of ART can support the number of births and fertility rates, especially past the age of 35.
Australia represents an illuminating case study among the group of low fertility countries as it has one of the highest ART utilization rates in the world (Chambers et al., 2021), partly explained by the relatively supportive funding arrangement through Australia’s universal healthcare system, Medicare. The scheme covers approximately two-thirds of total costs for an unlimited number of ART cycles, with no restrictions based on age, number of cycles, or parity—limitations commonly in place in other countries (Allan et al., 2019). This absence of an age limit for publicly funded access to infertility treatment distinguishes Australia from most other countries and places it in a unique position to investigate the contribution of ART to fertility at advanced reproductive ages.
Fertility Trends and Late Childbearing Desires in Australia
Completed cohort fertility of successive generations of Australian women has been steadily declining to an average of 2.0 children among women born in 1967–1971 (Lazzari, 2021). Such decline was accompanied by a rise in permanent childlessness, from 9.6% for women born in 1950 to 15.2% for women born in 1968,Footnote 1 and by a continuous increase in the mean age at childbearing from 25.4 in 1971 (Australian Bureau of Statistics, 2001) to 30.6 in 2017 (Australian Institute of Health and Welfare, 2019a), mainly driven by the postponement of first births. Since the beginning of the 1980s, the prevalence of late (40 +) births also shifted from 1.2% to 4.8% in 2017. Similar changes occurred in other low fertility countries (Beaujouan, 2020; Billari et al., 2007). Moreover, repartnering has become common among divorced and separated women (Gray, 2015), which further contributes to the rising fertility at later reproductive ages.
Shifts in the timing of fertility are also reflected in recent surveys of reproductive intentions, with rising shares of Australian women in their 30s or 40s wishing to have a child in the future. Figure 1 illustrates the increase in the proportion of women wishing to have at least one (more) child between 2001 and 2016. This trend is more pronounced among women aged 35–39 (from 24.7% to 33.6%) and 40–44 (from 9.3% to 13.6%). Desiring more children is closely associated with being childless or having one child, although, among women aged 35 and above, desires seem to be growing even for those with two or more children. The distinction between compositional factors (age and parity) is essential for interpreting trends in childbearing desires and to understand individual motivations behind the increasing demand for ART as women typically resort to these technologies after their mid-30 s, especially to have a first child (Lazzari et al., 2021).
Taken together, the increase in childbearing desires at advanced reproductive ages and the age-related decline in the biological capacity to reproduce suggest that assisted reproduction is likely to become more important for future fertility trends. Indeed, ART can help reducing the gap between desired and achieved number of births as it provides an opportunity for women, men, and couples to partly reconcile the mismatch between the desired and biologically optimal age to have children. Arguably, the increase in the prevalence of late births and rising use of reproductive technologies are linked (Billari et al., 2007), and ART may partly support fertility at older ages by helping women to fulfill their reproductive desires at an age when many of them experience infertility.
Materials and Methods
To predict the future contribution of ART to CFR, the model brings together information on three distinct factors that influence this contribution: (1) cohort postponement of childbearing to later ages when the risk of experiencing infertility is higher; (2) changes in the uptake of ART treatments; and (3) changes in ART success rates. Our data do not allow us to distinguish each individual treatment. Rather, we analyze the share of women receiving at least one treatment at each age and, in turn, the share of women at each age having an ART-conceived child after receiving one or more treatments (success rate). Dependencies between these three components and their impact on ART births and total births are shown in the causal loop diagram in Fig. 2.
The total number of ART births is directly influenced by ART treatment and success rates and indirectly shaped by further childbearing postponement, which leads to a higher proportion of women seeking to have children at older ages when their reproductive potential diminishes. Figure 2 also shows links between treatment and success rates: an increase in the effectiveness of treatments may encourage higher utilization, while an increase in the use of ART may further support advances in the technology. The main outcome variable, the total number of births, is lowered by childbearing postponement, although ART births can partly compensate for such decline.
Data Sources
The total number of ART births and treatments by age performed in Australia between 2010 and 2017 are sourced from the Australia and New Zealand Assisted Reproduction Database (ANZARD), a clinical registry that collects information about all ART treatments performed in Australia and the resulting pregnancies and birth outcomes (Newman et al., 2021). Since all Australian fertility clinics are required to report ART birth outcome information to ANZARD as part of their licensing requirements, full registration of ART births can be assumed. To supplement these data, we collected information on the total annual number of ART babies born to Australian women between 1998 and 2009 from the annual ANZARD reports. ART age-specific fertility rates for the period 1998–2009 are estimated by combining these absolute numbers with the relative ART age-specific fertility profile as observed in 2010. In combination, we were able to reconstruct and estimate ART treatments and births over a twenty-year period, 1998–2017. Fertility treatments that do not involve fertilization outside of the woman’s body, such as intrauterine insemination and ovulation induction, are not included because only births resulting from treatments involving ART are reported in ANZARD. Population birth data are drawn from the national birth registries (Australian Bureau of Statistics 2021a). The number of non-assisted births (conceived without ART) is obtained by subtracting the number of ART-conceived births from the number of total births in each year and by single age of mother.
The study takes a cohort perspective and focuses on women born in 1968–1986. The fertility of the cohort born in 1968 is complete and known, as these women reached age 49 in 2017, while projections are needed for later cohorts. All data on total and ART-related fertility occurring in 2018 and later are projected. The Lexis diagram displayed in Fig. S1 in section A of the Online Appendix material provides a visual representation of the data sources and analyzed cohorts.
Modelling the Role of ART on Completed Fertility
The completed fertility rate, or \({CFR}_{c}\left(x\right)\), of a cohort of women born in year \(c\) up to age \(x\) is computed as the sum of their age-specific fertility rates as:
where \({B}_{c}(x)\) is the number of births to women at age \(x\) born in year \(c\), and \({W}_{c}(x)\) is the number of women in the population at age \(x\) born in year \(c.\) In order to study how ART influences the \({CFR}_{c}\left(x\right)\), Eq. (1) is reformulated as the sum of ART and non-ART age-specific fertility rates, as:
where \({B}_{c}^{ART}\left(x\right)\) indicates births conceived through ART and \({B}_{c}^{N}\) indicates births conceived without ART. ART age-specific fertility rates can be further decomposed as follows:
where
corresponds to the ART age-specific treatment rate (the proportion of women of age \(x\) born in year \(c\) receiving ART treatment out of all women of age \(x\) born in year \(c\) in the population) and
corresponds to the ART age-specific success rate (the number of ART-conceived babies born to women of age \(x\) and born in year \(c\) out of all women of age \(x\) born in year \(c\) receiving ART treatment).
The decomposition in Eq. (3) is suitable for the purpose of analysing the role of a change in the demand for reproductive treatments and success rates in determining the contribution of ART to age-specific fertility rates. This way of measuring success rates differs from the medical literature, where success is typically computed as the ratio of the number of treatment cycles to live births. Instead, the method used in this study reflects the age-specific probability that a woman undergoing ART treatment in a given year will be successful in having a desired birth.
Cohort Fertility Forecasting
The forecasting of non-ART age-specific fertility rates is accomplished by using the linear five-year extrapolation method by Myrskylä et al., (2013). Inspired by the Lee-Carter model for period mortality (Lee & Carter, 1992) and Lee’s model for period fertility (Lee, 1993), this method is designed to estimate incomplete cohort fertility. The method extrapolates the trend in period age-specific fertility rates five years into the future based on the trend observed over the past five years, and then freezes the rates (Myrskylä et al., 2013) (the details of the method are provided in section B of the Online Appendix). In our study, this corresponds to forecasting period fertility rates from 2017 (the most recently observed year) to 2022.
In a recent assessment of twenty methodologies to forecast CFR, the five-year extrapolation method has been evaluated as the most accurate and outperforming more sophisticated forecasting models (Bohk-Ewald et al., 2018). This method is also preferred to using unlimited linear extrapolation, or the simpler freeze-rate approach, which assumes that the forecasted age-specific fertility rates will stay the same as in the most recent year, thus underestimating potential fertility recovery at higher ages when fertility timing is changing.
Projection Scenarios of ART Fertility Rates
Five scenarios of ART fertility rates are formulated, based on different assumptions regarding future ART success rates and treatment rates (in Fig. 4). They are combined with the forecasted non-ART age-specific fertility rates, resulting in five alternative trajectories of future completed fertility accounting for the contribution of ART.Footnote 2
-
1.
No-change scenario (S1) assumes no further improvement in success rates and no further increase in treatment rates. Success and treatment rates remain fixed at their level observed in 2017.
-
2.
Extrapolated success rates scenario (S2) assumes improving success rates combined with an unchanged use of ART. Success rates are extrapolated five years into the future, from 2018 to 2022, based on the five previous years, and then kept fixed at their latest extrapolated level. Treatment rates remain fixed at the level observed in 2017. This means that further increases in the number of ART births are solely due to improvements in the technology.
-
3.
Extrapolated treatment rates scenario (S3) explores the impact of increasing demand for ART among cohorts as they age in combination with stable success rates (fixed at the level observed in 2017). Treatment rates are extrapolated five years into the future, from 2018 to 2022, based on the five previous years and are then kept fixed at their latest extrapolated level. This means that further increases in the number of ART births are solely due to increased utilization of treatments.
-
4.
In the Extrapolated success and treatment rates scenario (S4) both success and treatment rates are extrapolated up to 2022 and then kept fixed at their 2022 level.
-
5.
Egg donation and freezing scenario (S5) assumes high ART success rates for women over 40 due to increased use of donor eggs and/or frozen eggs. The practice of using donor eggs is most common among women above the age of 45, explaining the relatively high success rates at these ages. In this scenario, we compute the average success rates at age 46–49 for the period 2018–2022 and apply it to all women aged 40 and above. Our extrapolated ART success rates below age 40 remain the same as in scenarios 2 and 4, while extrapolated treatment rates are identical to scenarios 3 and 4.
While scenarios 2 and 3 are useful to disentangle the effect of an increase in ART treatment and success rates, it is unlikely that one will occur without the other. Hence, we consider the Extrapolated success and treatment rates scenario (S4) as the most plausible scenario, reflecting the likely improvement in both ART treatment and success rates. The No-change scenario (S1) should be seen as a benchmark to evaluate the impact of projected changes compared to a situation without further increases in treatment rates and improvements in success rates. The Egg donation and freezing scenario (S5) illustrates a hypothetical situation where all women aged 40 and above would suddenly shift from using own fresh eggs to using frozen or third-party donor eggs after 2017. It provides insights into the potential future contribution of ART to fertility at late reproductive ages, should egg freezing become more widespread. While supply constraints, cost, legislation, and ethical concerns may prevent wider spread of donor eggs (Gleicher et al., 2020), recent evidence suggests a dramatic increase in the utilization of egg freezing in Australia (Johnston et al., 2021). This suggests that as more women are choosing to freeze their eggs at younger ages, which are closer to the biologically optimal age (Human Fertilisation and Embryology Authority 2018; Johnston et al., 2021), the use of oocyte cryopreservation may become increasingly important in influencing future fertility trends.
Australian research has linked the increasing demand for fertility treatment with educational change (Raymer et al., 2019), as highly educated women are more likely to delay family formation and, hence, to experience infertility. Moreover, access to ART care in Australia markedly differs across socio-economic groups (Lazzari et al., 2022). Between the cohorts of women born in 1968 and 1986, there has been a substantial educational expansion, with the proportion of tertiary educated women increasing from below 30% to 45% (Australian Bureau of Statistics 2021b). Our modelling strategy has indirectly incorporated the effect of this compositional shift in the scenarios assuming a rising trend in ART usage. As a robustness check, we evaluated how our results would change if we explicitly included educational attainment in the projection model (see section C in the Online Appendix). We found no substantial differences to the results presented in the next section.
Projection Scenarios of ART Contribution to Fertility Recuperation
This study uses and builds upon the benchmark model of fertility postponement and recuperation (Frejka & Calot, 2001; Lesthaeghe, 2001) to investigate the impact of ART to these processes.
Fertility postponement and recuperation (recovery) can be measured for each cohort of interest in comparison with an older (reference) cohort. In the postponement phase, the cumulative completed fertility rate of successive cohorts is lower than that of the reference cohort because fertility at younger ages is declining, while in the recuperation phase, the cumulative difference gradually decreases as fertility at older ages is increasing relative to the reference cohort. If part of the “postponed” fertility is not recuperated later in life, it translates into a permanent decline in CFR across cohorts.
Using a benchmark cohort of interest, this framework allows a clear comparison of what proportion of postponed fertility has been recuperated or foregone relative to that cohort. The method is also particularly suitable for investigating how these proportions of recuperated or foregone fertility rates would change under different circumstances affecting fertility recuperation. For instance, the availability of ART partly relaxes reproductive constraints at older ages, allowing for higher recuperation levels as compared to a situation where ART is not available. Such contribution can be computed by first quantifying how much of the observed decline in cohort fertility below a certain age m is projected to be recovered after that age, relative to the reference cohort, and then by quantifying the proportion of such recuperation that is attributable to ART.
Figure 3 shows how would these processes change with and without the availability of ART treatments. The cumulative fertility falls relative to the reference cohort until reaching a maximum difference at age m, which corresponds to the age of 30 for the cohorts analysed in this study, after which the fertility “gap” between these two cohorts starts narrowing.
The absolute increase in cumulated cohort fertility between age m and the end of the reproductive life at age 49—as compared to the reference cohort—is a measure of absolute recovery. Figure 3 illustrates that the availability of ART contributes to this recovery and shows how this model can be used to compare different scenarios of ART uptake and success rates and to investigate the differences in fertility recuperation levels associated with these scenarios.
Results
Trends in Age-Specific Treatment and Success Rates
Estimated (2006–2009), observed (2010–2017), and projected (2018–2022) trends in ART success rates and treatment rates used in the projection model are displayed in Fig. 4. Between the ages of 30 and 45, success rates gradually decline: while approximately 40% of treated women in their early 30s can expect to give birth to an ART-conceived child, by the age of 45, this proportion dramatically drops (to 5% over the period 2011–2017, on average). Since 2011, however, there has been a rebound in success rates at age 45 and above. For example, while only 3.6% of women receiving ART treatment at age 46–49 gave birth in 2011, this proportion jumped to 15.6% in 2017 and it is projected to reach 28% in 2022. The projected increase in success rates after 2017 reflects the ongoing shifts away from more “traditional” ART treatments to oocyte cryopreservation and ART cycles using donor eggs (Newman et al., 2021).
The distribution of age-specific treatment rates (Fig. 4B) resembles that of total age-specific fertility rates, although with an older age profile. The mean age at treatment is projected to increase from 35.6 in 2006 to 36.4 in 2022. Over the period of analysis, treatment rates per 1000 women aged 35–40 are projected to increase by 44%, from an average of 18 in 2006 to 26 in 2022.
Projected Impact of ART on Completed Cohort Fertility
When contrasting the No-change scenario (S1) with a hypothetical situation where no ART treatment is available, the projection suggests that there will be a slight decline in CFR and that women born in 1986 will have 1.9 children, on average (see Fig. S4 in section D of the Online Appendix). This is an all-time low in Australia, although still above the ‘very-low’ cohort fertility threshold suggested at 1.75 (Zeman et al., 2018).
The decline in CFR would be sharper in the absence of infertility treatment. For instance, without births resulting from ART, the CFR of the 1986 cohort would reach 1.8, approximately 5% (or 0.1 children per woman) less than its total projected value. The contribution of ART is likely to increase over time, growing in importance for women that are currently around age 30 or younger.
Differences Between Scenarios
Figure 5 presents the projected relative contribution of ART use to CFR according to five alternative scenarios (the underlying numbers are shown in Table S3 in section D of the Online Appendix). All scenarios indicate a rising impact of ART on completed fertility, with the contribution of ART births to CFR more than doubling from 2.1% among women born in 1968 to 4.7–5.7% among women born in 1986. The impact of different scenarios becomes more distinct among women born in the late 1970s, who were around age 40 at the projection baseline. The slowest growth (to 4.7–4.8%) is projected by the No-change scenario (S1), which assumes no further change in success and treatment rates after 2017, and in the Extrapolated success rates scenario (S2). The Extrapolated treatment rates scenario (S3) shows a faster rise to 5.2% for the 1986 cohort, suggesting that increasing treatment rates may contribute more to future fertility than rising success rates of the treatments unless a significant improvement in technology brings about a faster improvement in success rates. This possibility is envisaged in the Egg donation and freezing scenario (S5), which projects greater contribution to CFR (almost 6% for the 1986 birth cohort). Although such a quick improvement in success rates at later ages is unlikely to materialize, this scenario sheds light on the potential impact of a fast adoption of egg freezing on late fertility.
Age-Specific Projections
When the share of ART births out of total births is broken down by age group and single birth cohort (Fig. 6), the results show that if both success and treatment rates continue to increase, as hypothesized in the Extrapolated success and treatment rates scenario (S4), the probability of having a child conceived through ART increases with age and over cohorts. For instance, the percentage ART contribution to fertility rates among women aged 40–44 increases from 11.9% in the 1968 cohort to 25.3% in the 1986 cohort and the increase is even steeper, from 8.0% to almost 40%, at age 45–49.
However, at these advanced reproductive ages, the total number of births is relatively low as most childbearing has taken place before age 40. Since ART has a negligeable impact on births at younger ages (below 30), the overall contribution of ART to fertility in Australia remains much lower, approximately 5 percent, than the observed impact at age 40 and above. Yet, our findings suggest that the increasing contribution to the CFR of fertility rates at older reproductive ages will be strongly supported by the increasing availability and use of ART. A smaller rise in ART births at later ages is obtained using the Extrapolated treatment rates scenario (S3) (not shown), with the percentage ART contribution to fertility rates increasing up to 23.0% for women aged 40–44 and 21.1% for women aged 45–49 born in 1986.
Projected Impact of ART on Fertility Recuperation
Figure 7 illustrates the projected dynamics of the postponement and recuperation processes for three selected cohorts (1974, 1980, and 1986), as compared to the reference cohort born in 1968. Supplementary information is provided in Table 1. With age, ART plays an increasingly important role in offsetting the decline in CFR. A partial recovery of births between the ages of 30 and 40 occurs, regardless of ART. However, past the age of 40, the increase in ART-conceived births becomes the only driver of further fertility recuperation. The absolute difference in recuperation between a hypothetical situation in which ART is not available and the Extrapolated success and treatment rates scenario (S4) increases over cohorts, from 0.06 for the 1974 cohort to 0.09 for the 1986 cohort (Table 1). This pattern reflects the greater reliance of women and couples on ART in fulfilling their childbearing desires at advanced reproductive ages and the increasing demand for ART as a family building option across generations.
In the 1974 cohort, fertility recovery after age 30 is complete when considering ART births. Among women born in 1980, 81.2% of births delayed before age 30 (compared to the 1968 reference cohort) would eventually be realized, according to the Extrapolated success and treatment rates scenario (S4). The projected recuperation is 78.5% under the No-change scenario (S1) and 83% under the Egg donation and freezing scenario (S5). In the youngest cohort born in 1986, recuperation is projected to drop to 58.6% under S4, with approximately half of such recuperation attributable to ART. Hence, while the use of ART substantially contributes to women having births at older reproductive ages, it will not fully compensate for the decline in CFR.
Study Limitations
When estimating the potential impact of ART on CFR, modelling assumptions and potential limitations should be acknowledged. First, this study assumes that births conceived through ART would not have happened without the treatment. However, some couples having an ART birth would have eventually conceived spontaneously (Cahill et al., 2005; de La Rochebrochard et al., 2009; Troude et al., 2012), leading to an overestimation of the actual impact of ART on fertility levels.
Second, the availability of ART may trigger unintended behavioural responses by encouraging couples to stay childless for longer (Abramowitz, 2014 & 2017; Rainer et al., 2011; Gershoni & Low, 2021), hence increasing their risk of experiencing infertility and of underachieving their reproductive plans. This is especially relevant when considering the widespread misconceptions in the population regarding the biological limits to reproduction and the chances of achieving conception and birth at later ages via ART (Pedro et al., 2018).
Third, the higher incidence of multiple births following ART deliveries inflates the estimated contribution of these procedures to fertility rates. Though the rate of multiple births following ART cycles has decreased in Australia, from a peak of 22.1% in 2000 (Dean & Sullivan, 2003) to 2.9% in 2017 (Newman et al., 2021), it is still higher than the rate of multiple deliveries from all conceptions (1.5%) (Australian Institute of Health and Welfare, 2019b). Hence, especially among older cohorts, the contribution of ART to CFR is partly attributable to the higher incidence of multiple births. Ultimately, the magnitude to which multiple births bias our results depends on the extent to which couples using ART wish to have only one or more than one child. For the latter group, a multiple pregnancy is contributing to the faster achievement of the desired family size and, hence, does not imply an overestimation of births.
Fourth, the data and methods used do not allow for a more detailed analysis of the relationship between fertility postponement, ART fertility, and non-ART fertility. Arguably, the main factor in this interaction is the ongoing shift to later parenthood, which reduces the number of naturally conceived births due to infertility and increases the demand for and use of ART. More subtle mechanisms and interactions also play a role, as conceptualized in Fig. 2. For instance, improved chances of ART conception can boost ART fertility, increase demand for treatments, and thus suppress non-ART fertility rates at younger ages. Couples in successive cohorts may be more willing to use ART, which then lowers the chances of achieving a non-ART pregnancy and birth. In addition, attitudes towards ART may change over time and alter the relationship between ART fertility and fertility postponement. Properly modeling these interactions would require detailed assumptions about fertility preferences, demand for ART, numbers of cycles used, and ‘natural’ (non-ART) fertility rates among women from different cohorts, which is beyond the scope of our study. However, we indirectly account for the impact of delayed parenthood on ART births in scenarios S3–S5, which assume an ongoing increase in the use of ART.
Another limitation lies in the implicit assumption of our extrapolation method of linear growth in ART treatment and success rates. Linear trends may not always be accurate, as events such as the COVID-19 pandemic can disrupt the provision and uptake of ART treatment in unexpected ways (Rodriguez-Wallberg & Wikander, 2020). Although the adoption of a cohort approach reduces the bias introduced by changes in fertility timing, other shocks and technological changes may be more difficult to anticipate. For instance, it is plausible that ART success rates may increase more sharply in the future because of the introduction of new treatments and advancements in reproductive technology. Aware of these uncertainties, our projections adopt a conservative approach by limiting trend extrapolation to a five-year forecast horizon, taking into account the potential for unforseen changes in demand for ART, technology, and childbearing postponement.
Discussion
Using data from a comprehensive clinical registry of ART treatments and births, we projected the contribution of ART to completed fertility in Australia under five alternative scenarios. The percentage contribution of ART to completed fertility is estimated to increase from 2.1% among women born in 1968 to between 4.7% and 5.7% among women born in 1986. The relative contribution of ART will more than double between the analysed cohorts even in the most conservative No-change scenario (S1). The probability of having an ART-conceived child increases with age and across cohorts. In the youngest cohorts (1980–1986), approximately one in three children born to women aged 45–49 and one in four children born to women aged 40–44 are expected to be conceived via ART. Our findings are robust across scenarios and the adoption of a cohort approach implies that results are not sensitive to short-term changes in treatment rates and success rates introduced by temporary shocks, including temporary disruption to ART provision during the recent COVID-19 pandemic. Even in the most conservative No-change scenario (S1) in which we assumed that there will be no further increases in the demand for ART and no improvements in the effectiveness of treatments after the last observed year, 2017, the contribution of ART is substantial and increasing due to the continuation of the trend towards childbearing postponement among the youngest cohorts.
The in-depth analysis of the contribution of ART to fertility by age adopting a cohort approach is essential for evaluating fertility trends as well as fertility ‘recuperation’ at later ages in low fertility countries. While most past research focused on the impact of ART on overall fertility (Habbema et al., 2009; Hoorens et al., 2007; Leridon, 2017; Leridon & Slama, 2008; Sobotka et al., 2008), our results demonstrate that ART substantially contributes to fertility at older reproductive ages and corroborate previous research demonstrating the crucial role played by ART in increasing period fertility rates past the age of 40 (Lazzari et al., 2021).
Our scenarios suggest that increases in ART fertility rates will be mainly driven by an increase in the demand for infertility treatment. However, the diffusion of alternative treatment options, such as egg freezing and the use of third-party donor eggs, may lead to a sharp rise in ART success rates and alter these dynamics in the future. Our study also explored the extent to which postponed childbearing will be compensated at older ages due to ART. Compared to a hypothetical situation where treatment is not available, the fertility recuperation among cohorts of women currently in their early to mid-30s (born between 1982 and 1986) is twice as large when ART is considered. Remarkably, further fertility recovery after age 40 is almost entirely attributable to ART-conceived births.
ART is constantly advancing. New methods may further improve success rates and increase the number of ART births beyond our projected trends Biological relatedness is important to many people, which suggests that oocyte cryopreservation may be more widely acceptable than donor methods (Shreffler et al., 2010). The growing number of women freezing their eggs supports this idea (Johnston et al., 2021), although elective egg freezing remains a controversial technology, with high psychological and monetary costsFootnote 3 for prospective mothers (Jackson, 2018).
This study has a broader relevance for demographers and policymakers, as it sheds light on the potential role of ART for future fertility. The growing use of ART reflects broader changes in family formation in low fertility countries, which include a long-term shift of parenthood to older reproductive ages (Beaujouan, 2020; Mills et al., 2011). More women are having children past the age of 30 due to delays in partnership and marriage, as well as more frequent second and third partnerships after breakups and separations (Thomson et al., 2014). Because of the biological constraints on fertility, ART births are likely to make up an increasing proportion of children. Hence, the general finding on the important role of ART in fertility recuperation highlighted by this study is likely to hold across all the countries experiencing the postponement transition. Such contribution can be leveraged especially in settings where there is no upper age limit set by law to access treatments, like in Australia. In countries with different ART funding arrangements and regulations, the overall contribution of treatments to cohort fertility will likely vary. Hence, the results from this study can be more easily generalizable to settings with generous public systems for infertility treatment and high ART utilization rates. These conditions are met especially in the Nordic countries (Wyns et al., 2020).
As childbearing before the age of 30 continues to decline, a compensatory increase in fertility rates at later ages will become crucial for supporting future fertility levels. Advances in reproductive technologies have likely pushed the upper age limit of fertility to new extremes, as noted by Billari et al., (2007, p. 166). However, an effort to empirically analyse the impact of ART on late and very late fertility is only recently emerging in the demographic literature. Our study contributes to this research area by demonstrating that ART may become an important contextual driver of fertility recovery.
Data availability
The data on which this article is based cannot be shared publicly for confidentiality reasons.
Notes
Own computations based on Australian Bureau of Statistics (ABS) data.
This study adopts a deterministic approach to predict future cohort fertility and the likely contribution of ART. In our model, uncertainty is incorporated through the elaboration of alternative scenarios about future conditions affecting the number, share, and rate of ART births among the analysed cohorts.
Egg freezing is an expensive medical procedure even in countries with a supportive funding environment for ART like Australia because it is not typically covered by Medicare and by any other national insurance schemes since it is not considered clinically necessary.
References
Abramowitz, J. (2014). Turning back the ticking clock: The effect of increased affordability of assisted reproductive technology on women’s marriage timing. Journal of Population Economics, 27, 603–633.
Abramowitz, J. (2017). Assisted reproductive technology and women’s timing of marriage and childbearing. Journal of Family and Economic Issues, 38, 100–117.
Allan, S., Balaban, B., Banker, M., Buster, J., Horton, M., Miller, K., Mocanu, E., Ory, S. J., Pai, H., der Poelcan, S., & Zegers-Hochschild, F. (2019). International federation of fertility societies’ surveillance (IFFS) (2019): Global trends in reproductive policy and practice. Global Reproductive Health, 4(1), 1–138.
Australian Bureau of Statistics (ABS). (2001). Australian social trends. Canberra: ABS.
Australian Bureau of Statistics (ABS). (2021a). 3301.0 Births, Australia. Canberra: Australian Bureau of Statistics. Available at: https://www.abs.gov.au/
Australian Bureau of Statistics (ABS). (2021b). 2016 Census – Counting Persons, Place of usual Residence, Table Builder Pro. https://www.abs.gov.au/websitedbs/censushome.nsf/home/ tablebuilder
Australian Institute of Health and Welfare (AIHW). (2019). Australia’s mothers and babies 2017—in brief. Canberra: AIHW.
Australian Institute of Health and Welfare (AIHW). (2019). The health of Australia’s females. Canberra: AIHW.
Beaujouan, É. (2020). Latest-late fertility? Decline and resurgence of late parenthood across the low-fertility countries. Population and Development Review, 46(2), 219–247.
Billari, F. C., Kohler, H.-P., Andersson, G., & Lundström, H. (2007). Approaching the limit: Long-term trends in late and very late fertility. Population and Development Review, 33(1), 149–170.
Birenbaum-Carmeli, D., & Dirnfeld, M. (2008). In vitro fertilization policy in Israel and women’s perspectives: The more the better? Reproductive Health Matters, 16(31), 182–191.
Blyth, E., Lee, G. L., & Yee, S. (2013). Freezing the Biological Clock: A Viable Fertility Preservation Option for Young Singaporean Women? Annals, Academy of Medicine Singapore, 42(9), 472–477.
Bohk-Ewald, C., Peng, L., & Myrskylä, M. (2018). Forecast accuracy hardly improves with method complexity when completing cohort fertility. Proceedings of the National Academy of Sciences of the United States of America, 115(37), 9187-9192.
Burcin, B., Pachlová, T., Šťastná, A., & Kocourková, J. (2020). Assessment of the contribution of assisted reproduction methods for the future development of the number of live births in Czechia. Preprint available at Research Square. https://doi.org/10.21203/rs.3.rs-40688/v1
Cahill, D. J., Meadowcroft, J., Akande, V. A., & Corrigan, E. (2005). Likelihood of natural conception following treatment by IVF. Journal of Assisted Reproduction and Genetics, 22, 401–405.
Chambers, G. M., Dyer, S., Zegers-Hochschild, F., de Mouzon, J., Ishihara, O., Banker, M., MansourKUpka, R. M., & Adamson, G. D. (2021). International committee for monitoring assisted reproductive technologies world report: Assisted reproductive technology, 2014. Human Reproduction, 36(11), 2921–2934.
Chambers, G. M., Hoang, V. P., Sullivan, E. A., Chapman, M. G., Ishihara, O., Zegers-Hochschild, F., Nygren, K. G., & Adamson, G. D. (2014). The impact of consumer affordability on access to assisted reproductive technologies and embryo transfer practices: An international analysis. Fertility and Sterility, 101(1), 191–198.
de La Rochebrochard, E., Quelen, C., Peikrishvili, R., Guibert, J., & Bouyer, J. (2009). Long-term outcome of parenthood project during in vitro fertilization and after discontinuation of unsuccessful in vitro fertilization. Fertility and Sterility, 92, 149–156.
Dean, J. H., & Sullivan, E. A. (2003). Assisted conception Australia and New Zealand 2000 and 2001. National Perinatal Epidemiology and Statistics Unit. The University of New South Wales.
Eijkemans, M. J. C., van Poppel, F., Habbema, D. F., Smith, K. R., Leridon, H., & te Velde, E. R. (2014). Too old to have children? Lessons from natural fertility populations. Human Reproduction, 29(6), 1304–1312.
Frejka, T., & Calot, G. (2001). Cohort reproductive patterns in low-fertility countries. Population and Development Review, 27(1), 103–132.
Gershoni, N., & Low, C. (2021). Older yet fairer: How extended reproductive time horizons reshaped marriage patterns in Israel. American Economic Journal: Applied Economics, 13(1), 198–234.
Gleicher, N., Baradm, D. H., & Adashi, E. Y. (2020). Why is use of donor eggs not viewed as treatment failure? A call for improvements in treatments with autologous oocytes. Journal of Assisted Reproduction and Genetics, 37, 1585–1588.
Gray, E. (2015). Repartnering. In G. Heard & D. Arunachalam (Eds.), Family formation in 21st century Australia (pp. 101–121). Springer.
Gray, E., Reimondos, A., Lazzari, E., Breunig, R., Steinhauser, R., Zhang, J., Biddle, N., & Gray, M. (2021). Impacts of policies in fertility rates. Canberra: The Australian Government.
Habbema, J. D. F., Eijkemans, M. J. C., Nargund, G., Beets, G., Leridon, H., & te Velde, E. R. (2009). The effects of in vitro fertilization on birth rates in western countries. Human Reproduction, 24(6), 1414–1419.
Hoorens, S., Gallo, F., Cave, J. A. K., & Grant, J. C. (2007). Can assisted reproductive technologies help to offset population ageing? An assessment of the demographic and economic impact of ART in Denmark and UK. Human Reproduction, 22(9), 2471–2475.
Human Fertilisation and Embryology Authority (HFEA). (2018). Egg freezing in fertility treatment. HFEA.
International Committee Monitoring ART, & ESHRE. (2018, July 3). Annual collection of global IVF data [Press release]. Retrieved from https://www.eshre.eu/Annual-Meeting/Barcelona-2018/ESHRE-2018 -Press-releases/De-Geyter
Jackson, E. (2018). The ambiguities of ‘social’ egg freezing and the challenges of informed consent. BioSocieties, 13(1), 21–40.
Johnston, M., Richings, N. M., Leung, A., Sakkas, D., & Catt, S. (2021). A major increase in oocyte cryopreservation cycles in the USA, Australia and New Zealand since 2010 is highlighted by younger women but a need for standardized data collection. Human Reproduction, 36(3), 624–635.
Kim, S. (2019). Reproductive technologies as population control: How pronatalist policies harm reproductive health in South Korea. Sexual and Reproductive Health Matters, 27(2), 6–12.
Lazzari, E. (2021). Changing trends between education, childlessness and completed fertility: A cohort analysis of Australian women born in 1952–1971. Journal of Population Research, 38, 417–441.
Lazzari, E., Baffour, B., & Chambers, G. (2022). Residential proximity to a fertility clinic is independently associated with likelihood of women having ART and IUI treatment. Human Reproduction, 37(11), 2662–2671.
Lazzari, E., Gray, E., & Chambers, G. (2021). The contribution of assisted reproductive technology to fertility rates and parity transition: An analysis of Australian data. Demographic Research, 45(35), 1081–1096.
Lee, R. D. (1993). Modeling and forecasting the time series of US fertility: Age distribution, range, and ultimate level. International Journal of Forecasting, 9(2), 187–202.
Lee, R. D., & Carter, L. R. (1992). Modeling and forecasting US mortality. Journal of the American Statistical Association, 87(419), 659–671.
Leridon, H. (2004). Can assisted reproductive technology compensate for the natural decline in fertility with age? A Model Assessment. Human Reproduction, 7(19), 1548–1553.
Leridon, H. (2017). Biological Effects of First Birth Postponement and Assisted Reproductive Technology on Completed Fertility. Population, 72(3), 445–472.
Leridon, H., & Slama, R. (2008). The impact of a decline in fecundity and of pregnancy postponement on final number of children and demand for assisted reproduction technology. Human Reproduction, 23(6), 1312–1319.
Lesthaeghe, R. (2001). Postponement and recuperation: Recent fertility trends and forecasts in six Western European countries. International Union for the Scientific Study of Population (IUSSP) Seminar on. International Perspectives on Low Fertility: Trends Theories and Policies.
McCarter, K., Setton, R., Chung, A., An, A., Rosenwaks, Z., & Spandorfer, S. (2021). Is increasing paternal age negatively associated with donor oocyte recipient success? A paired analysis using sibling oocytes. Fertility and Sterility, 116(2), 373–379.
McCurry, J. (2020). Japan to help cover IVF costs in attempt to avert demographic crisis. The Guardian. Available at: https://www.theguardian.com/world/2020/nov/06/japan-to-help-cover-ivf-costs-in-attempt-to-avert-demographic-crisis
Mills, M., Rindfuss, R., McDonald, P., & te Velde, E. (2011). Why do people postpone parenthood? Reasons and social policy incentives. Human Reproduction Update, 17(6), 848–860.
Mladovsky, P., & Sorenson, C. (2010). Public financing of IVF: A review of policy rationales. Health Care Analysis, 18(2), 113–128.
Myrskylä, M., Goldstein, J. R., & Cheng, Y. A. (2013). New cohort fertility forecast for the developed world: Rises, falls and reversals. Population and Development Review, 39(1), 31–56.
Newman, J.E., Paul, G.M., & Chambers, G.M. (2021). Assisted reproductive technology in Australia and New Zealand 2019. National Perinatal Epidemiology and Statistics Unit, the University of New South Wales, Sydney. https://npesu.unsw.edu.au/ data-collection/australian-new-zealand-assisted-reproduction-database-anzard
Pedro, J., Brandão, T., Schmidt, L., Costa, M. E., & Martins, M. V. (2018). What do people know about fertility? A systematic review on fertility awareness and its associated factors. Upsala Journal of Medical Sciences, 123(2), 71–81.
Präg, P., & Mills, M. (2017). Assisted reproductive technology in Europe: Usage and regulation in the context of cross-border reproductive care. In M. Kreyenfeld & D. Konietzka (Eds.), Childlessness in Europe: Contexts, Causes, and Consequences (pp. 289–309). Springer Publishing.
Rainer, H., Selvaretnam, G., & Ulph, D. (2011). Assisted reproductive technologies (ART) in a model of fertility choice. Journal of Population Economics, 24, 1101–1132.
Raymer, J., Guan, Q., Norman, R. J., Ledger, W., & Chambers, G. M. (2019). Projecting future utilization of medically assisted fertility treatments. Population Studies, 74(1), 23–38.
Rodriguez-Wallberg, K., & Wikander, I. (2020). A global recommendation for restrictive provision of fertility treatments during the COVID-19 pandemic. Acta Obstetricia Et Gynecologica Scandinavica, 99(5), 569–570.
Sartorius, G. A., & Nieschlag, E. (2010). Paternal age and reproduction. Human Reproduction, 16(1), 65–79.
Shreffler, K. M., Johnson, D. R., & Scheuble, L. K. (2010). Ethical problems with infertility treatments: attitudes and explanations. The Social Science Journal, 47(4), 731–746.
Sobotka, T., Hansen, M. A., Jensen, A. T., Lutz, W., & Skakkebæk, N. E. (2008). The contribution of assisted reproduction to completed fertility: An analysis of danish data. Population and Development Review, 34(1), 79–101.
Sobotka, T., Matysiak, A., & Brzozowska, Z. (2019). Policy responses to low fertility How effective are they? India: United Nations Population Funds.
Sobotka, T., Zeman, K., Lesthaeghe, R., Frejka, T., & Neels, K. (2012). Postponement and recuperation in cohort fertility: Austria, Germany and Switzerland in an European context. Comparative Population Studies, 36(2–3), 417–452.
Thomson, E., Lappegård, T., Carlson, M., Evans, A., & Gray, E. (2014). Childbearing across partnerships in Australia, the United States, Norway and Sweden. Demography, 51, 485–508.
Tierney, K. (2022). The future of assisted reproductive technology live births in the United States. Population Research and Policy Review, 41(5), 1–21.
Troude, P., Bailly, E., Guibert, J., Bouyer, J., & de La Rochebrochard, E. (2012). Spontaneous pregnancies among couples previously treated by in vitro fertilization. Fertility and Sterility, 98, 63–68.
Wyns, C., Bergh, C., Calhaz-Jorge, C., De Geyter, C., Kupka, M. S., Motrenko, T., Rugescu, I., Smeenk, J., Tandler-Schneider, A., Vidakovic, S., & Goossens, V. (2020). ART in Europe 2016: results generated from European registries by ESHRE. Human Reproduction Open, 2020(3), hoaa032.
Zeman, K., Beaujouan, É., Brzozowska, Z., & Sobotka, T. (2018). Cohort fertility decline in low fertility countries: Decomposition using parity progression ratios. Demographic Research, 38(25), 651–690.
Acknowledgements
Prior versions of this paper were presented as part of the 2021 International Population Conference (virtual) and as part of the 2022 European Population Conference at the University of Groningen, Netherlands.
Funding
Part of the research presented in this paper was developed during the Young Scientist Summer Program at the International Institute for Applied Systems Analysis, Laxenburg, Austria. This research was partly supported by funding received from the European Research Council (ERC) under the European Union's Horizon 2020 research and innovation programme (grant Agreement No. 101001410). Open access funding was provided by the University of Vienna.
Author information
Authors and Affiliations
Corresponding author
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Lazzari, E., Potančoková, M., Sobotka, T. et al. Projecting the Contribution of Assisted Reproductive Technology to Completed Cohort Fertility. Popul Res Policy Rev 42, 6 (2023). https://doi.org/10.1007/s11113-023-09765-3
Received:
Accepted:
Published:
DOI: https://doi.org/10.1007/s11113-023-09765-3